시장보고서
상품코드
2035822

인공지능(AI) 바이오 컴퓨팅 빅 모델 시장 보고서(2026년)

Artificial Intelligence (AI) Biocomputing Big Model Global Market Report 2026

발행일: | 리서치사: 구분자 The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

가격
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 4,490 금액 안내 화살표 ₩ 6,949,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 금액 안내 화살표 ₩ 10,045,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 금액 안내 화살표 ₩ 13,140,000
※ 부가세 별도
한글목차
영문목차

인공지능(AI) 바이오 컴퓨팅 빅 모델 시장 규모는 최근 비약적으로 성장하고 있습니다. 이 시장은 2025년 43억 8,000만 달러에서 2026년에는 52억 9,000만 달러에 달하고, CAGR 20.6%로 성장할 전망입니다. 지난 수년간의 성장은 유전체학 및 단백질체학 연구의 발전, 계산생물학에 대한 관심 증가, 딥러닝 프레임워크의 도입, 제약 및 생명공학 분야의 연구개발(R&:D) 확대, 분자간 상호작용 예측에 대한 수요 증가에 기인하는 것으로 분석됩니다. 것으로 예측됩니다.

인공지능(AI) 바이오 컴퓨팅·빅 모델 시장 규모는 향후 몇 년간 비약적인 성장이 전망되고 있습니다. 2030년에는 112억 7,000만 달러에 이르고, CAGR은 20.8%를 보일 전망입니다. 예측 기간 동안 성장 요인으로는 하이브리드 AI 바이오컴퓨팅 시스템 도입 확대, 맞춤형 의료 용도에 대한 수요 증가, 대규모 생물학적 모델 채택 확대, 클라우드 기반 바이오인포매틱스 서비스 확대, 의료 및 농업 데이터와의 통합 발전 등을 꼽을 수 있습니다. 예측 기간 동안 주요 동향으로는 클라우드 기반 바이오인포매틱스 플랫폼의 채택 확대, 고성능 컴퓨팅 하드웨어에 대한 수요 증가, 멀티오믹스 데이터 분석 툴의 통합 발전, 시뮬레이션 및 디지털 트윈 소프트웨어 용도의 확대, AI 바이오컴퓨팅에 대한 교육 및 훈련 서비스에 대한 관심 증가 등이 있습니다. AI 바이오컴퓨팅 관련 교육 및 트레이닝 서비스에 대한 관심 증가 등을 꼽았습니다.

맞춤형 의료에 대한 수요 증가는 향후 몇 년 동안 인공지능(AI) 바이오컴퓨팅 빅모델 시장의 성장을 견인할 것으로 예측됩니다. 맞춤형 의료란 개인의 유전적, 분자적, 임상적 특성에 따라 의료적 개입을 맞춤화하는 것을 말합니다. 유전체 분석 및 기타 하이스루풋 바이오 기술의 발전으로 환자 데이터의 양과 복잡성이 크게 증가하면서 임상적으로 의미 있는 결과를 도출하기 위한 고도의 계산 기법이 필요하게 되었습니다. AI 바이오컴퓨팅 빅모델은 유전체학, 단백질체학, 의료영상, 전자건강기록 등 멀티모달 데이터 세트를 처리할 수 있는 대규모 AI 시스템으로, 질병 위험 예측, 치료 최적화 및 치료법 맞춤화를 대규모로 촉진하여 맞춤형 의료를 지원합니다. 의료를 지원합니다. 예를 들어, 미국 비영리단체인 Personalized Medicine Coalition의 보고서에 따르면, 2024년 2월 기준 미국 식품의약국(FDA)은 2023년 희귀질환 환자를 위한 16개의 새로운 개인 맞춤형 치료제를 승인할 것으로 예상하고 있습니다. 16건을 승인했으며, 이는 2022년 6건에서 증가한 수치입니다. 따라서 맞춤형 의료에 대한 수요 증가가 인공지능(AI) 바이오컴퓨팅 빅모델 시장의 성장을 견인하고 있습니다.

제약 연구개발(R&:D) 노력의 확대는 AI 바이오컴퓨팅 빅모델 시장의 성장을 가속할 것으로 예측됩니다. 제약 R&&D는 제약사, 생명공학 기업 및 연구기관이 새로운 치료법을 발견, 개발 및 개선하기 위한 체계적인 노력을 포함합니다. 제약 R&&D에 대한 투자 확대는 신약 개발 효율 향상, 개발 기간 단축, 복잡한 질병에 대한 대응의 필요성에 의해 촉진되고 있으며, 그 결과 고도의 계산 기술에 대한 의존도가 높아지고 있습니다. AI 바이오컴퓨팅 빅모델은 멀티오믹스 데이터, 분자 구조, 임상시험 정보 및 실제 데이터를 대규모로 분석할 수 있게 함으로써 제약 R&&D에서 매우 중요한 역할을 하고 있습니다. 이러한 모델은 표적 식별, 리드 화합물 최적화, 독성 예측 및 환자 계층화를 지원하여 신약 개발 파이프라인 전반의 의사결정을 강화합니다. 예를 들어, 영국 정부 기관인 국가통계청(Office for National Statistics)에 따르면, 2023년 영국 정부의 R&D 순지출은 2022년 161억 파운드(204억 5,000만 달러)에서 174억 파운드(221억 달러)로 증가하여 8.2%의 성장률을 보일 것으로 예측됩니다.%의 성장률을 기록했습니다. 따라서 연구개발 활동의 확대가 AI 바이오컴퓨팅 빅모델 시장 확대를 견인하고 있습니다.

자주 묻는 질문

  • 인공지능(AI) 바이오 컴퓨팅 빅 모델 시장 규모는 어떻게 변화할 것으로 예상되나요?
  • AI 바이오 컴퓨팅 빅 모델 시장의 주요 성장 요인은 무엇인가요?
  • 맞춤형 의료의 수요 증가는 AI 바이오 컴퓨팅 빅 모델 시장에 어떤 영향을 미치나요?
  • 제약 연구개발(R&D) 확대가 AI 바이오 컴퓨팅 빅 모델 시장에 미치는 영향은 무엇인가요?
  • AI 바이오 컴퓨팅 빅 모델의 주요 기능은 무엇인가요?

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 시장 및 업계 지표 : 국가별

제11장 지역별/국가별 분석

제12장 아시아태평양 시장

제13장 중국 시장

제14장 인도 시장

제15장 일본 시장

제16장 호주 시장

제17장 인도네시아 시장

제18장 한국 시장

제19장 대만 시장

제20장 동남아시아 시장

제21장 서유럽 시장

제22장 영국 시장

제23장 독일 시장

제24장 프랑스 시장

제25장 이탈리아 시장

제26장 스페인 시장

제27장 동유럽 시장

제28장 러시아 시장

제29장 북미 시장

제30장 미국 시장

제31장 캐나다 시장

제32장 남아메리카 시장

제33장 브라질 시장

제34장 중동 시장

제35장 아프리카 시장

제36장 시장 규제 상황과 투자환경

제37장 경쟁 구도와 기업 개요

제38장 기타 주요 기업 및 혁신 기업

제39장 세계 시장 경쟁 벤치마킹과 대시보드

제40장 시장에서 주목 받는 스타트업

제41장 주요 인수합병(M&A)

제42장 시장 잠재력이 높은 국가, 부문, 전략

제43장 부록

LSH 26.06.04

An artificial intelligence (AI) biocomputing big model is a large-scale AI system designed to analyze complex biological and biomedical data, including genomics, proteomics, and multi-omics datasets. It uses deep learning and generative modeling to predict molecular interactions, identify biomarkers, and support applications such as personalized medicine and drug discovery.

The primary components of artificial intelligence biocomputing big model include hardware, software, and services. Hardware includes high-performance computing systems and processors used to support complex biological data analysis and large-scale model training. These solutions incorporate models such as large biological models, deep learning frameworks, bioinformatics platforms, and simulation and digital twin software. Deployment occurs through on-premises, cloud-based, and hybrid models. Applications include genome sequencing, protein structure prediction, and other areas, serving end users such as pharmaceutical and biotechnology companies, research institutions and academia, healthcare providers, agricultural firms, environmental and conservation organizations, and government research labs.

Tariffs on imported high-performance computing hardware, AI accelerators, and specialized bioinformatics equipment are impacting the AI biocomputing big model market by increasing production and deployment costs, particularly affecting hardware and cloud deployment segments. Regions such as North America, Europe, and Asia-Pacific, which rely on imported servers, GPUs, and data storage systems, are most affected. While tariffs raise costs, they also encourage local manufacturing, drive regional innovation in cost-efficient AI hardware, and promote domestic service providers, supporting long-term market resilience and self-reliance.

The artificial intelligence (AI) biocomputing big model market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI) biocomputing big model market statistics, including artificial intelligence (AI) biocomputing big model industry global market size, regional shares, competitors with a artificial intelligence (AI) biocomputing big model market share, detailed artificial intelligence (AI) biocomputing big model market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) biocomputing big model industry. This artificial intelligence (AI) biocomputing big model market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence (AI) biocomputing big model market size has grown exponentially in recent years. It will grow from $4.38 billion in 2025 to $5.29 billion in 2026 at a compound annual growth rate (CAGR) of 20.6%. The growth in the historic period can be attributed to growth in genomics and proteomics research, increasing computational biology initiatives, adoption of deep learning frameworks, expansion of pharmaceutical and biotech R&D, rising need for molecular interaction prediction.

The artificial intelligence (AI) biocomputing big model market size is expected to see exponential growth in the next few years. It will grow to $11.27 billion in 2030 at a compound annual growth rate (CAGR) of 20.8%. The growth in the forecast period can be attributed to increasing deployment of hybrid AI biocomputing systems, growing demand for personalized medicine applications, rising adoption of large biological models, expansion of cloud-based bioinformatics services, increasing integration with healthcare and agricultural data. Major trends in the forecast period include increasing adoption of cloud-based bioinformatics platforms, rising demand for high-performance computing hardware, growing integration of multi-omics data analysis tools, expansion of simulation and digital twin software applications, rising focus on training and education services for ai biocomputing.

The increasing demand for personalized medicine is anticipated to fuel the expansion of the artificial intelligence (AI) biocomputing big model market in the coming years. Personalized medicine refers to customizing healthcare interventions according to an individual's genetic, molecular, and clinical attributes. Progress in genomic and other high-throughput biological technologies has substantially expanded the volume and complexity of patient data, generating a requirement for advanced computational methods to derive clinically meaningful insights. AI biocomputing big models are large-scale AI systems capable of processing multi-modal datasets such as genomics, proteomics, medical imaging, and electronic health records, supporting personalized medicine by facilitating disease risk prediction, treatment optimization, and therapy customization at scale. For example, in February 2024, as reported by the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the US Food and Drug Administration approved 16 new personalized treatments for rare disease patients, an increase from six in 2022. Therefore, the rising demand for personalized medicine is propelling the growth of the artificial intelligence (AI) biocomputing big model market.

The expansion of pharmaceutical research and development (R&D) initiatives is projected to stimulate the growth of the AI biocomputing big model market. Pharmaceutical R&D encompasses structured efforts by drug manufacturers, biotechnology firms, and research organizations to discover, develop, and refine new therapies. Growing investment in pharmaceutical R&D is driven by the necessity to enhance drug discovery efficiency, shorten development timelines, and tackle complex diseases, thereby heightening reliance on advanced computational technologies. AI biocomputing big models serve a vital function in pharmaceutical R&D by facilitating large-scale analysis of multi-omics data, molecular structures, clinical trial information, and real-world evidence. These models assist in target identification, lead optimization, toxicity forecasting, and patient stratification, thereby strengthening decision-making throughout the drug development pipeline. For example, in 2023, according to the Office for National Statistics, a UK-based government agency, the UK government's net spending on research and development rose to £17.4 billion ($22.1 billion), compared with £16.1 billion ($20.45 billion) in 2022, marking an 8.2% increase. Therefore, the growth in research and development activities is driving the expansion of the AI biocomputing big model market.

The expanding use of health monitoring devices is expected to accelerate the growth of the AI biocomputing big model market in the foreseeable future. Health monitoring devices are medical or wearable technologies intended to continuously or periodically gather and evaluate physiological data to determine an individual's health condition and support timely medical care. The rising adoption of health monitoring devices is fueled by the increasing prevalence of chronic diseases, as continuous real-time tracking allows early intervention, improved disease management, and lower hospitalization rates. AI biocomputing big models strengthen health monitoring devices by processing large-scale, multi-parameter physiological data in real time to identify subtle patterns, forecast health risks, deliver personalized insights, and enable proactive, precision-focused interventions. For example, in August 2025, as reported by the Office of Inspector General, a US-based independent organization, the number of Medicare beneficiaries utilizing remote patient monitoring grew substantially, reaching nearly 1 million in 2024, representing a 27% increase compared to 2023. Therefore, the increasing adoption of health monitoring devices is propelling the growth of the AI biocomputing big model market.

Major companies operating in the artificial intelligence (AI) biocomputing big model market are Microsoft Corporation, Alibaba Group Holding Limited, Huawei Technologies Co. Ltd., Siemens AG, International Business Machines Corporation, Oracle Corporation, Nvidia Corporation, Generate Biomedicines Inc., Owkin Inc., Nabla Bio Inc., Arzeda Corp., Evozyne Inc., BigHat Biosciences Inc., AI Proteins Inc., Cradle B.V., Profluent Bio Inc., Absci Corporation, Biomatter Designs UAB, Insilico Medicine Ltd., and Variant Bio Inc.

North America was the largest region in the artificial intelligence (AI) biocomputing big model market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) biocomputing big model market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial intelligence (AI) biocomputing big model market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence (AI) biocomputing big model market includes revenues earned by entities providing services such as model training and fine-tuning, cloud-based model hosting and inference, custom model development, and integration into enterprise or research workflows. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The artificial intelligence (AI) biocomputing big model market consists of sales of products such as large-scale biological foundation models, genomic and proteomic prediction engines, molecular simulation AI systems, drug discovery models, and multimodal bio-AI models. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence (AI) Biocomputing Big Model Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses artificial intelligence (ai) biocomputing big model market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence (ai) biocomputing big model ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai) biocomputing big model market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Component: Hardware; Software; Services
  • 2) By Model: Large Biological Models; Deep Learning Frameworks; Bioinformatics Platforms; Simulation And Digital Twin Software
  • 3) By Deployment Mode: On-Premise; Cloud-Based; Hybrid
  • 4) By Application: Genome Sequencing; Protein Structure Prediction; Other Applications
  • 5) By End-User Industry: Pharmaceutical And Biotechnology; Research Institutions And Academia; Healthcare Providers; Agricultural Firms; Environmental And Conservation Organizations; Government Research Labs
  • Subsegments:
  • 1) By Hardware: Processors; Graphics Processing Units; High Performance Computing Systems; Data Storage Systems; Networking And Interconnect Equipment; Artificial Intelligence Accelerators; Bioinformatics Workstations
  • 2) By Software: Model Development And Training Software; Bioinformatics Analysis Software; Simulation And Modeling Software; Data Management And Integration Software; Visualization And Interpretation Software; Workflow And Pipeline Management Software
  • 3) By Services: Consulting And Strategy Services; System Integration Services; Cloud Deployment And Infrastructure Services; Technical Support And Maintenance Services; Data Analysis And Model Optimization Services; Training And Education Services
  • Companies Mentioned: Microsoft Corporation; Alibaba Group Holding Limited; Huawei Technologies Co. Ltd.; Siemens AG; International Business Machines Corporation; Oracle Corporation; Nvidia Corporation; Generate Biomedicines Inc.; Owkin Inc.; Nabla Bio Inc.; Arzeda Corp.; Evozyne Inc.; BigHat Biosciences Inc.; AI Proteins Inc.; Cradle B.V.; Profluent Bio Inc.; Absci Corporation; Biomatter Designs UAB; Insilico Medicine Ltd.; and Variant Bio Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Artificial Intelligence (AI) Biocomputing Big Model Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Artificial Intelligence (AI) Biocomputing Big Model Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Artificial Intelligence (AI) Biocomputing Big Model Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Artificial Intelligence (AI) Biocomputing Big Model Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption of Cloud-Based Bioinformatics Platforms
    • 4.2.2 Rising Demand for High-Performance Computing Hardware
    • 4.2.3 Growing Integration of Multi-Omics Data Analysis Tools
    • 4.2.4 Expansion of Simulation and Digital Twin Software Applications
    • 4.2.5 Rising Focus on Training and Education Services for AI Biocomputing

5. Artificial Intelligence (AI) Biocomputing Big Model Market Analysis Of End Use Industries

  • 5.1 Pharmaceutical And Biotechnology Firms
  • 5.2 Research Institutions And Academia
  • 5.3 Healthcare Providers
  • 5.4 Agricultural Firms
  • 5.5 Government Research Labs

6. Artificial Intelligence (AI) Biocomputing Big Model Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Artificial Intelligence (AI) Biocomputing Big Model Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Artificial Intelligence (AI) Biocomputing Big Model PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Artificial Intelligence (AI) Biocomputing Big Model Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Artificial Intelligence (AI) Biocomputing Big Model Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Artificial Intelligence (AI) Biocomputing Big Model Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Artificial Intelligence (AI) Biocomputing Big Model Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Artificial Intelligence (AI) Biocomputing Big Model Market Segmentation

  • 9.1. Global Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hardware, Software, Services
  • 9.2. Global Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Large Biological Models, Deep Learning Frameworks, Bioinformatics Platforms, Simulation And Digital Twin Software
  • 9.3. Global Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • On-Premise, Cloud-Based, Hybrid
  • 9.4. Global Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Genome Sequencing, Protein Structure Prediction, Other Applications
  • 9.5. Global Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By End-User Industry, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pharmaceutical And Biotechnology, Research Institutions And Academia, Healthcare Providers, Agricultural Firms, Environmental And Conservation Organizations, Government Research Labs
  • 9.6. Global Artificial Intelligence (AI) Biocomputing Big Model Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Processors, Graphics Processing Units, High Performance Computing Systems, Data Storage Systems, Networking And Interconnect Equipment, Artificial Intelligence Accelerators, Bioinformatics Workstations
  • 9.7. Global Artificial Intelligence (AI) Biocomputing Big Model Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Model Development And Training Software, Bioinformatics Analysis Software, Simulation And Modeling Software, Data Management And Integration Software, Visualization And Interpretation Software, Workflow And Pipeline Management Software
  • 9.8. Global Artificial Intelligence (AI) Biocomputing Big Model Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Consulting And Strategy Services, System Integration Services, Cloud Deployment And Infrastructure Services, Technical Support And Maintenance Services, Data Analysis And Model Optimization Services, Training And Education Services

10. Artificial Intelligence (AI) Biocomputing Big Model Market, Industry Metrics By Country

  • 10.1. Global Artificial Intelligence (AI) Biocomputing Big Model Market, Average Selling Price By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $
  • 10.2. Global Artificial Intelligence (AI) Biocomputing Big Model Market, Average Spending Per Capita (Employed) By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $

11. Artificial Intelligence (AI) Biocomputing Big Model Market Regional And Country Analysis

  • 11.1. Global Artificial Intelligence (AI) Biocomputing Big Model Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 11.2. Global Artificial Intelligence (AI) Biocomputing Big Model Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. Asia-Pacific Artificial Intelligence (AI) Biocomputing Big Model Market

  • 12.1. Asia-Pacific Artificial Intelligence (AI) Biocomputing Big Model Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. Asia-Pacific Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. China Artificial Intelligence (AI) Biocomputing Big Model Market

  • 13.1. China Artificial Intelligence (AI) Biocomputing Big Model Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 13.2. China Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. India Artificial Intelligence (AI) Biocomputing Big Model Market

  • 14.1. India Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Japan Artificial Intelligence (AI) Biocomputing Big Model Market

  • 15.1. Japan Artificial Intelligence (AI) Biocomputing Big Model Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 15.2. Japan Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Australia Artificial Intelligence (AI) Biocomputing Big Model Market

  • 16.1. Australia Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Indonesia Artificial Intelligence (AI) Biocomputing Big Model Market

  • 17.1. Indonesia Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. South Korea Artificial Intelligence (AI) Biocomputing Big Model Market

  • 18.1. South Korea Artificial Intelligence (AI) Biocomputing Big Model Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. South Korea Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Taiwan Artificial Intelligence (AI) Biocomputing Big Model Market

  • 19.1. Taiwan Artificial Intelligence (AI) Biocomputing Big Model Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. Taiwan Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. South East Asia Artificial Intelligence (AI) Biocomputing Big Model Market

  • 20.1. South East Asia Artificial Intelligence (AI) Biocomputing Big Model Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. South East Asia Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Western Europe Artificial Intelligence (AI) Biocomputing Big Model Market

  • 21.1. Western Europe Artificial Intelligence (AI) Biocomputing Big Model Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 21.2. Western Europe Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. UK Artificial Intelligence (AI) Biocomputing Big Model Market

  • 22.1. UK Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. Germany Artificial Intelligence (AI) Biocomputing Big Model Market

  • 23.1. Germany Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. France Artificial Intelligence (AI) Biocomputing Big Model Market

  • 24.1. France Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Italy Artificial Intelligence (AI) Biocomputing Big Model Market

  • 25.1. Italy Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Spain Artificial Intelligence (AI) Biocomputing Big Model Market

  • 26.1. Spain Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Eastern Europe Artificial Intelligence (AI) Biocomputing Big Model Market

  • 27.1. Eastern Europe Artificial Intelligence (AI) Biocomputing Big Model Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 27.2. Eastern Europe Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Russia Artificial Intelligence (AI) Biocomputing Big Model Market

  • 28.1. Russia Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. North America Artificial Intelligence (AI) Biocomputing Big Model Market

  • 29.1. North America Artificial Intelligence (AI) Biocomputing Big Model Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. North America Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. USA Artificial Intelligence (AI) Biocomputing Big Model Market

  • 30.1. USA Artificial Intelligence (AI) Biocomputing Big Model Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. USA Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. Canada Artificial Intelligence (AI) Biocomputing Big Model Market

  • 31.1. Canada Artificial Intelligence (AI) Biocomputing Big Model Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. Canada Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. South America Artificial Intelligence (AI) Biocomputing Big Model Market

  • 32.1. South America Artificial Intelligence (AI) Biocomputing Big Model Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 32.2. South America Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Brazil Artificial Intelligence (AI) Biocomputing Big Model Market

  • 33.1. Brazil Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Middle East Artificial Intelligence (AI) Biocomputing Big Model Market

  • 34.1. Middle East Artificial Intelligence (AI) Biocomputing Big Model Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Middle East Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Africa Artificial Intelligence (AI) Biocomputing Big Model Market

  • 35.1. Africa Artificial Intelligence (AI) Biocomputing Big Model Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 35.2. Africa Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

36. Artificial Intelligence (AI) Biocomputing Big Model Market Regulatory and Investment Landscape

37. Artificial Intelligence (AI) Biocomputing Big Model Market Competitive Landscape And Company Profiles

  • 37.1. Artificial Intelligence (AI) Biocomputing Big Model Market Competitive Landscape And Market Share 2024
    • 37.1.1. Top 10 Companies (Ranked by revenue/share)
  • 37.2. Artificial Intelligence (AI) Biocomputing Big Model Market - Company Scoring Matrix
    • 37.2.1. Market Revenues
    • 37.2.2. Product Innovation Score
    • 37.2.3. Brand Recognition
  • 37.3. Artificial Intelligence (AI) Biocomputing Big Model Market Company Profiles
    • 37.3.1. Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 37.3.2. Alibaba Group Holding Limited Overview, Products and Services, Strategy and Financial Analysis
    • 37.3.3. Huawei Technologies Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 37.3.4. Siemens AG Overview, Products and Services, Strategy and Financial Analysis
    • 37.3.5. International Business Machines Corporation Overview, Products and Services, Strategy and Financial Analysis

38. Artificial Intelligence (AI) Biocomputing Big Model Market Other Major And Innovative Companies

  • Oracle Corporation, Nvidia Corporation, Generate Biomedicines Inc., Owkin Inc., Nabla Bio Inc., Arzeda Corp., Evozyne Inc., BigHat Biosciences Inc., AI Proteins Inc., Cradle B.V., Profluent Bio Inc., Absci Corporation, Biomatter Designs UAB, Insilico Medicine Ltd., Variant Bio Inc.

39. Global Artificial Intelligence (AI) Biocomputing Big Model Market Competitive Benchmarking And Dashboard

40. Upcoming Startups in the Market

41. Key Mergers And Acquisitions In The Artificial Intelligence (AI) Biocomputing Big Model Market

42. Artificial Intelligence (AI) Biocomputing Big Model Market High Potential Countries, Segments and Strategies

  • 42.1. Artificial Intelligence (AI) Biocomputing Big Model Market In 2030 - Countries Offering Most New Opportunities
  • 42.2. Artificial Intelligence (AI) Biocomputing Big Model Market In 2030 - Segments Offering Most New Opportunities
  • 42.3. Artificial Intelligence (AI) Biocomputing Big Model Market In 2030 - Growth Strategies
    • 42.3.1. Market Trend Based Strategies
    • 42.3.2. Competitor Strategies

43. Appendix

  • 43.1. Abbreviations
  • 43.2. Currencies
  • 43.3. Historic And Forecast Inflation Rates
  • 43.4. Research Inquiries
  • 43.5. The Business Research Company
  • 43.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
kr-info@giikorea.co.kr
문의하기